COVID and the Renin-Angiotensin System: Are Hypertension or Its Treatments Deleterious?

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2020 May 12

PMID 32391384

Citations 23

Authors

Florian Zores

Mathieu E Rebeaud

Affiliations

Soon will be listed here.

Citing Articles

Association of COVID-19 with Comorbidities: An Update.

Chatterjee S, Nalla L, Sharma M, Sharma N, Singh A, Malim F ACS Pharmacol Transl Sci. 2023; 6(3):334-354.

PMID: 36923110 PMC: 10000013. DOI: 10.1021/acsptsci.2c00181.

Association of ACE2 Gene Variants with the Severity of COVID-19 Disease-A Prospective Observational Study.

Sienko J, Marczak I, Kotowski M, Bogacz A, Tejchman K, Sienko M Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231922 PMC: 9564490. DOI: 10.3390/ijerph191912622.

Curcumin to inhibit binding of spike glycoprotein to ACE2 receptors: computational modelling, simulations, and ADMET studies to explore curcuminoids against novel SARS-CoV-2 targets.

Shanmugarajan D, P P, Prashantha Kumar B, Suresh B RSC Adv. 2022; 10(52):31385-31399.

PMID: 35520671 PMC: 9056388. DOI: 10.1039/d0ra03167d.

Angiotensin-converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end-stage kidney disease.

Arefin S, Hernandez L, Ward L, Schwarz A, Barany P, Stenvinkel P Eur J Clin Invest. 2022; 52(8):e13786.

PMID: 35366343 PMC: 9541326. DOI: 10.1111/eci.13786.

Association between COVID-19 Diagnosis and Coronary Artery Thrombosis: A Narrative Review.

Nappi F, Giacinto O, Ellouze O, Nenna A, Avtaar Singh S, Chello M Biomedicines. 2022; 10(3).

PMID: 35327504 PMC: 8945192. DOI: 10.3390/biomedicines10030702.

References

Halliday B, Wassall R, Lota A, Khalique Z, Gregson J, Newsome S . Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial. Lancet. 2018; 393(10166):61-73. PMC: 6319251. DOI: 10.1016/S0140-6736(18)32484-X. View

Batlle D, Wysocki J, Satchell K . Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?. Clin Sci (Lond). 2020; 134(5):543-545. DOI: 10.1042/CS20200163. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A . Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-1581. PMC: 7136855. DOI: 10.1001/jama.2020.5394. View

Oudit G, Kassiri Z, Jiang C, Liu P, Poutanen S, Penninger J . SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009; 39(7):618-25. PMC: 7163766. DOI: 10.1111/j.1365-2362.2009.02153.x. View

Imai Y, Kuba K, Rao S, Huan Y, Guo F, Guan B . Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature. 2005; 436(7047):112-6. PMC: 7094998. DOI: 10.1038/nature03712. View

Huang F, Guo J, Zou Z, Liu J, Cao B, Zhang S . Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun. 2014; 5:3595. PMC: 7091598. DOI: 10.1038/ncomms4595. View

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F . Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020; 5(7):802-810. PMC: 7097841. DOI: 10.1001/jamacardio.2020.0950. View

Gu H, Xie Z, Li T, Zhang S, Lai C, Zhu P . Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus. Sci Rep. 2016; 6:19840. PMC: 4728398. DOI: 10.1038/srep19840. View

10.

Ferrario C, Jessup J, Chappell M, Averill D, Brosnihan K, Tallant E . Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation. 2005; 111(20):2605-10. DOI: 10.1161/CIRCULATIONAHA.104.510461. View

11.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo F, Chong M . Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. JAMA. 2020; 323(16):1612-1614. PMC: 7082763. DOI: 10.1001/jama.2020.4326. View

12.

Yang X, Deng W, Tong Z, Liu Y, Zhang L, Zhu H . Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection. Comp Med. 2007; 57(5):450-9. View

13.

Farcas G, Poutanen S, Mazzulli T, Willey B, Butany J, Asa S . Fatal severe acute respiratory syndrome is associated with multiorgan involvement by coronavirus. J Infect Dis. 2004; 191(2):193-7. PMC: 7109982. DOI: 10.1086/426870. View

14.

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

15.

Burrell L, Risvanis J, Kubota E, Dean R, Macdonald P, Lu S . Myocardial infarction increases ACE2 expression in rat and humans. Eur Heart J. 2005; 26(4):369-75. DOI: 10.1093/eurheartj/ehi114. View

16.

Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T . Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients. Circ Res. 2005; 97(9):946-53. DOI: 10.1161/01.RES.0000187500.24964.7A. View

17.

Kuba K, Imai Y, Ohto-Nakanishi T, Penninger J . Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther. 2010; 128(1):119-28. PMC: 7112678. DOI: 10.1016/j.pharmthera.2010.06.003. View

18.

Heurich A, Hofmann-Winkler H, Gierer S, Liepold T, Jahn O, Pohlmann S . TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein. J Virol. 2013; 88(2):1293-307. PMC: 3911672. DOI: 10.1128/JVI.02202-13. View

19.

Chen L, Li X, Chen M, Feng Y, Xiong C . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020; 116(6):1097-1100. PMC: 7184507. DOI: 10.1093/cvr/cvaa078. View

20.

Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M . Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats. Am J Hypertens. 2007; 20(10):1119-24. DOI: 10.1016/j.amjhyper.2007.05.008. View